ATEA PHARMACEUTICALS, INC. — Income Charts
4 quarters of history · ending 2021-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$192M
R&D
$58M
D&A
$7K
Operating Income
$121M
EBITDA
$121M
Other Income/Expense
$51K
Pretax Income
$121M
Tax Provision
$4M
Net Income
$117M
Operating Margin
63.1%
Net Margin
60.9%
Effective Tax Rate
3.4%
ETR (Continuing Operations)
12.5%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
3.2%
Operating Lease Cost
$70K
Income YoY Variation
1736.4%
Revenue QoQ Variation
485.7%
Income QoQ Variation
647.2%